Advertisement
Research Article| Volume 53, ISSUE 3, P198-206, March 2009

Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines: Trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress condition

      Abstract

      Background

      Epidermolysis bullosa simplex (EBS) is an autosomal inherited mechano-bullous disease, characterized by intraepidermal blistering and skin fragility caused by mutations in the keratin (KRT) 5 or 14 genes. Despite a vast knowledge about the intermediate filament pathology in this disease, the progress in therapy has been slow. Animal models and well-characterized continuous cell culture models of EBS are needed prior to clinical testing.

      Objectives

      Our aim was to generate immortalized cell lines as an in vitro model for the study of EBS and test a chemical chaperone, trimethylamine N-oxide (TMAO), as a putative novel therapy.

      Methods

      We generated four immortalized cell lines, two each from an EBS patient with a KRT5-mutation (V186L) and a healthy control, using human papillomavirus 16 (HPV16) E6E7 as transducer. Cell lines were established in serum-free and serum-containing medium and assessed for growth characteristics, keratin expression profiles, ability to differentiate in organotypic cultures, and response to heat stress with and without the presence of TMAO.

      Results

      All cell lines have been expanded >160 population doublings and their cellular characteristics are similar. However, the formation of cytoplasmic keratin filament aggregates in response to heat-shock treatment differed between EBS and normal cell lines. Notably, serum-free established EBS-cell line was most vulnerable to heat shock but both cell lines exhibited significant reduction in the number of keratin aggregates containing cells by TMAO.

      Conclusion

      The immortalized cell lines represent a suitable model for studying novel therapies for EBS. TMAO is a promising new agent for future development as a novel EBS therapy.

      Abbreviations:

      EBS (epidermolysis bullosa simplex), DAPI (4′-6-diamidino-2-phenylindole), DED (de-epidermized dermis), HPV16 E6/E7 (human papilloma virus 16 E6–E7 proteins), KRT (keratin), TGm1 (transglutaminase-1), PBS (phosphate-buffered saline), PCR (polymerase chain reaction), TMAO (trimethylamine N-oxide dihydrate)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rugg E.L.
        • Leigh I.M.
        The keratins and their disorders.
        Am J Med Genet C: Semin Med Genet. 2004; 131: 4-11
        • Lane E.B.
        • McLean W.H.
        Keratins and skin disorders.
        J Pathol. 2004; 204: 355-366
        • Hatzfeld M.
        • Weber K.
        Modulation of keratin intermediate filament assembly by single amino acid exchanges in the consensus sequence at the C-terminal end of the rod domain.
        J Cell Sci. 1991; 99: 351-362
        • Fine J.D.
        • Eady R.A.
        • Bauer E.A.
        • et al.
        The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on diagnosis and classification of EB.
        J Am Acad Dermatol. 2008; 58: 931-950
        • Ishida-Yamamoto A.
        • McGrath J.A.
        • Chapman S.J.
        • Leigh I.M.
        • Lane E.B.
        • Eady R.A.
        Epidermolysis bullosa simplex (Dowling–Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14.
        J Invest Dermatol. 1991; 97: 959-968
        • Kitajima Y.
        • Inoue S.
        • Yaoita H.
        Abnormal organization of keratin intermediate filaments in cultured keratinocytes of epidermolysis bullosa simplex.
        Arch Dermatol Res. 1989; 281: 5-10
        • Fichorova R.N.
        • Rheinwald J.G.
        • Anderson D.J.
        Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins.
        Biol Reprod. 1997; 57: 847-855
        • Morley S.M.
        • Dundas S.R.
        • James J.L.
        • Gupta T.
        • Brown R.A.
        • Sexton C.J.
        • et al.
        Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients.
        J Cell Sci. 1995; 108: 3463-3471
        • D’Alessandro M.
        • Russell D.
        • Morley S.M.
        • Davies A.M.
        • Lane E.B.
        Keratin mutations of epidermolysis bullosa simplex alter the kinetics of stress response to osmotic shock.
        J Cell Sci. 2002; 115: 4341-4351
        • Baskakov I.V.
        • Kumar R.
        • Srinivasan G.
        • Ji Y.S.
        • Bolen D.W.
        • Thompson E.B.
        Trimethylamine N-oxide-induced cooperative folding of an intrinsically unfolded transcription-activating fragment of human glucocorticoid receptor.
        J Biol Chem. 1999; 274: 10693-10696
        • Brown C.R.
        • Hong-Brown L.Q.
        • Biwersi J.
        • Verkman A.S.
        • Welch W.J.
        Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.
        Cell Stress Chaperones. 1996; 1: 117-125
        • Qu Y.
        • Bolen C.L.
        • Bolen D.W.
        Osmolyte-driven contraction of a random coil protein.
        Proc Natl Acad Sci USA. 1998; 95: 9268-9273
        • Street T.O.
        • Bolen D.W.
        • Rose G.D.
        A molecular mechanism for osmolyte-induced protein stability.
        Proc Natl Acad Sci USA. 2006; 103: 13997-14002
        • Voziyan P.A.
        • Fisher M.T.
        Chaperonin-assisted folding of glutamine synthetase under nonpermissive conditions: off-pathway aggregation propensity does not determine the co-chaperonin requirement.
        Protein Sci. 2000; 9: 2405-2412
        • Liovic M.
        • Stojan J.
        • Bowden P.E.
        • Gibbs D.
        • Vahlquist A.
        • Lane E.B.
        • et al.
        A novel keratin 5 mutation (K5V186L) in a family with EBS-K: a conservative substitution can lead to development of different disease phenotypes.
        J Invest Dermatol. 2001; 116: 964-969
        • Rheinwald J.G.
        • Green H.
        Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma.
        Cell. 1975; 6: 317-330
        • Akgul B.
        • Garcia-Escudero R.
        • Ghali L.
        • Pfister H.J.
        • Fuchs P.G.
        • Navsaria H.
        • et al.
        The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin.
        Cancer Res. 2005; 65: 2216-2223
        • Törmä H.
        • Geijer S.
        • Gester T.
        • Alpholm K.
        • Berne B.
        • Lindberg M.
        Variations in the mRNA expression of inflammatory mediators, markers of differentiation and lipid-metabolizing enzymes caused by sodium lauryl sulphate in cultured human keratinocytes.
        Toxicol In Vitro. 2006; 20: 472-479
        • Lincoln II, D.W.
        • Whitney R.G.
        • Smith J.R.
        In vitro proliferation and lifespan of bovine aorta endothelial cells: response to conditioned media.
        J Cell Sci. 1982; 56: 281-292
        • Barrandon Y.
        • Green H.
        Three clonal types of keratinocyte with different capacities for multiplication.
        Proc Natl Acad Sci USA. 1987; 84: 2302-2306
        • Poumay Y.
        • Dupont F.
        • Marcoux S.
        • Leclercq-Smekens M.
        • Herin M.
        • Coquette A.
        A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studies.
        Arch Dermatol Res. 2004; 296: 203-211
        • Fu B.
        • Quintero J.
        • Baker C.C.
        Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes.
        Cancer Res. 2003; 63: 7815-7824
        • Plug-DeMaggio A.W.
        • Sundsvold T.
        • Wurscher M.A.
        • Koop J.I.
        • Klingelhutz A.J.
        • McDougall J.K.
        Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6.
        Oncogene. 2004; 23: 3561-3571
        • McGhee E.M.
        • Cotter P.D.
        • Weier J.F.
        • Berline J.W.
        • Turner M.A.
        • Gormley M.
        • et al.
        Molecular cytogenetic characterization of human papillomavirus16-transformed foreskin keratinocyte cell line 16-MT.
        Cancer Genet Cytogenet. 2006; 168: 36-43
        • Poumay Y.
        • Pittelkow M.R.
        Cell density and culture factors regulate keratinocyte commitment to differentiation and expression of suprabasal K1/K10 keratins.
        J Invest Dermatol. 1995; 104: 271-276
        • Ortiz-Urda S.
        • Lin Q.
        • Yant S.R.
        • Keene D.
        • Kay M.A.
        • Khavari P.A.
        Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer.
        Gene Ther. 2003; 10: 1099-1104
        • Ortiz-Urda S.
        • Lin Q.
        • Green C.L.
        • Keene D.R.
        • Marinkovich M.P.
        • Khavari P.A.
        Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue.
        J Clin Invest. 2003; 111: 251-255
        • Magin T.M.
        • Kaiser H.W.
        • Leitgeb S.
        • Grund C.
        • Leigh I.M.
        • Morley S.M.
        • et al.
        Supplementation of a mutant keratin by stable expression of desmin in cultured human EBS keratinocytes.
        J Cell Sci. 2000; 113: 4231-4239
        • Borradori L.
        • Chavanas S.
        • Schaapveld R.Q.
        • Gagnoux-Palacios L.
        • Calafat J.
        • Meneguzzi G.
        • et al.
        Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion—reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes.
        Exp Cell Res. 1998; 239: 463-476
        • Santoro M.G.
        Heat shock factors and the control of the stress response.
        Biochem Pharmacol. 2000; 59: 55-63
        • D’Alessandro M.
        • Morley S.M.
        • Ogden P.H.
        • Liovic M.
        • Porter R.M.
        • Lane E.B.
        Functional improvement of mutant keratin cells on addition of desmin: an alternative approach to gene therapy for dominant diseases.
        Gene Ther. 2004; 11: 1290-1295
        • Wang A.
        • Bolen D.W.
        A naturally occurring protective system in urea-rich cells: mechanism of osmolyte protection of proteins against urea denaturation.
        Biochemistry. 1997; 36: 9101-9108
        • Forster R.P.
        • Goldstein L.
        Intracellular osmoregulatory role of amino acids and urea in marine elasmobranchs.
        Am J Physiol. 1976; 230: 925-931
        • Bai C.
        • Biwersi J.
        • Verkman A.S.
        • Matthay M.A.
        A mouse model to test the in vivo efficacy of chemical chaperones.
        J Pharmacol Toxicol Methods. 1998; 40: 39-45
        • Zou Q.
        • Bennion B.J.
        • Daggett V.
        • Murphy K.P.
        The molecular mechanism of stabilization of proteins by TMAO and its ability to counteract the effects of urea.
        J Am Chem Soc. 2002; 124: 1192-1202
        • Lin T.Y.
        • Timasheff S.N.
        Why do some organisms use a urea-methylamine mixture as osmolyte? Thermodynamic compensation of urea and trimethylamine N-oxide interactions with protein.
        Biochemistry. 1994; 33: 12695-12701
        • Virtanen M.
        • Törmä H.
        • Vahlquist A.
        Keratin 4 upregulation by retinoic acid in vivo: a sensitive marker for retinoid bioactivity in human epidermis.
        J Invest Dermatol. 2000; 114: 487-493
        • Kerns M.L.
        • DePianto D.
        • Dinkova-Kostova A.T.
        • Talalay P.
        • Coulombe P.A.
        Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex.
        Proc Natl Acad Sci USA. 2007; 104: 14460-14465